Cost Action GenE-Humdi(@GeneHumdi) 's Twitter Profile Photo

โ“Did you enjoyed the first Cost Action GenE-Humdi series.
๐Ÿ“ขHere comes the second!
๐Ÿ—“๏ธ June 11th, 3 pm CET
Learn and chat with Annarita Miccio Institut Imagine
Sign up today at CRISPR Medicine website!
crisprmedicinenews.com/cmn-webinars/gโ€ฆ

โ“Did you enjoyed the first @Genehumdi #YounResearchers #Webinar series.
๐Ÿ“ขHere comes the second!
๐Ÿ—“๏ธ June 11th, 3 pm CET
Learn and chat with Annarita Miccio @InstitutImagine
Sign up today at @CrisprMedicine website!
crisprmedicinenews.com/cmn-webinars/gโ€ฆ
account_circle
Ensoma(@EnsomaBio) 's Twitter Profile Photo

Ensoma VP of Gene Editing, Stefano Stella, recently spoke on base editing at in Copenhagen. We were proud to be a part of this inaugural CRISPR Medicine event and look forward to what's to come for these valuable events.

Ensoma VP of Gene Editing, Stefano Stella, recently spoke on base editing at #CRISPRMED24 in Copenhagen. We were proud to be a part of this inaugural @CrisprMedicine event and look forward to what's to come for these valuable events.
account_circle
F. Javier Molina E.(@tweet_Javi) 's Twitter Profile Photo

โ“Did you enjoyed the first Cost Action GenE-Humdi series.
๐Ÿ“ขHere comes the second!
๐Ÿ—“๏ธ June 11th, 3 pm CET
Learn and chat with Annarita Miccio Institut Imagine
Sign up today at CRISPR Medicine website!
crisprmedicinenews.com/cmn-webinars/gโ€ฆ

โ“Did you enjoyed the first @Genehumdi #YounResearchers #Webinar series. 
๐Ÿ“ขHere comes the second!
๐Ÿ—“๏ธ June 11th, 3 pm CET
Learn and chat with Annarita Miccio @InstitutImagine 
Sign up today at @CrisprMedicine website!
crisprmedicinenews.com/cmn-webinars/gโ€ฆ
account_circle
CRISPR Medicine(@CrisprMedicine) 's Twitter Profile Photo

๐‚๐‘๐ˆ๐’๐๐‘ ๐’๐œ๐ซ๐ž๐ž๐ง ๐‘๐ž๐ฏ๐ž๐š๐ฅ๐ฌ ๐“๐†๐…ฮฒ3 ๐š๐ฌ ๐๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ ๐จ๐Ÿ ๐๐š๐ฅ๐›๐จ๐œ๐ข๐œ๐ฅ๐ข๐› ๐‘๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐œ๐ž ๐ข๐ง ๐“๐ซ๐ข๐ฉ๐ฅ๐ž ๐๐ž๐ ๐š๐ญ๐ข๐ฏ๐ž ๐๐ซ๐ž๐š๐ฌ๐ญ ๐‚๐š๐ง๐œ๐ž๐ซ

The cyclin-dependent kinases (CDK) are essential regulators of the cell cycle, and it is

๐‚๐‘๐ˆ๐’๐๐‘ ๐’๐œ๐ซ๐ž๐ž๐ง ๐‘๐ž๐ฏ๐ž๐š๐ฅ๐ฌ ๐“๐†๐…ฮฒ3 ๐š๐ฌ ๐๐ข๐จ๐ฆ๐š๐ซ๐ค๐ž๐ซ ๐จ๐Ÿ ๐๐š๐ฅ๐›๐จ๐œ๐ข๐œ๐ฅ๐ข๐› ๐‘๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐œ๐ž ๐ข๐ง ๐“๐ซ๐ข๐ฉ๐ฅ๐ž ๐๐ž๐ ๐š๐ญ๐ข๐ฏ๐ž ๐๐ซ๐ž๐š๐ฌ๐ญ ๐‚๐š๐ง๐œ๐ž๐ซ

The cyclin-dependent kinases (CDK) are essential regulators of the cell cycle, and it is
account_circle
CRISPR Medicine(@CrisprMedicine) 's Twitter Profile Photo

๐Ÿ”‡ ๐๐‘๐„๐€๐Š๐ˆ๐๐† ๐๐„๐–๐’: ๐๐ž๐ฐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐‚๐€๐’๐“ ๐ฆ๐ž๐œ๐ก๐š๐ง๐ข๐ฌ๐ฆ๐ฌ

Scientists at Novo Nordisk Foundation Centre for Protein Research in Copenhagen have just published a major study in Molecular Cell, shedding new light on the mechanisms of

๐Ÿ”‡ ๐๐‘๐„๐€๐Š๐ˆ๐๐† ๐๐„๐–๐’: ๐๐ž๐ฐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐‚๐€๐’๐“ ๐ฆ๐ž๐œ๐ก๐š๐ง๐ข๐ฌ๐ฆ๐ฌ

Scientists at Novo Nordisk Foundation Centre for Protein Research in Copenhagen have just published a major study in Molecular Cell, shedding new light on the mechanisms of
account_circle
Unboxed.mag(@Unboxed_mag) 's Twitter Profile Photo

A new chapter in medicine: The FDA approves Casgevy, the first Crispr gene-editing therapy for sickle cell disease. A game-changer offering lasting relief for thousands. ๐Ÿงฌ

unboxedmagazine.com/news/a-new-eraโ€ฆ

A new chapter in medicine: The FDA approves Casgevy, the first Crispr gene-editing therapy for sickle cell disease. A game-changer offering lasting relief for thousands. ๐Ÿงฌ #GeneEditing #CrisprMedicine #SickleCellTreatment

unboxedmagazine.com/news/a-new-eraโ€ฆ
account_circle
Broken String Biosciences(@BrokenStringBio) 's Twitter Profile Photo

We are proud to be sponsoring the first CRISPR Medicine Conference , which will take place April 23-25 2024, in .

Early Bird registration ends on January 12th - learn more about the event and register at: event.fourwaves.com/crisprmed24/paโ€ฆ

CRISPR Medicine

We are proud to be sponsoring the first CRISPR Medicine Conference #CRISPRMED24,  which will take place April 23-25 2024, in #Copenhagen. 
 
Early Bird registration ends on January 12th - learn   more about the event and register at: event.fourwaves.com/crisprmed24/paโ€ฆ
 
@CRISPRmedicine
account_circle
CRISPR Medicine(@CrisprMedicine) 's Twitter Profile Photo

๐“๐ก๐ž ๐…๐ƒ๐€ ๐‡๐š๐ฌ ๐‚๐ฅ๐ž๐š๐ซ๐ž๐ ๐ญ๐ก๐ž ๐…๐ข๐ซ๐ฌ๐ญ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐š ๐๐ซ๐ข๐ฆ๐ž ๐„๐๐ข๐ญ๐จ๐ซ

Prime Medicine announced earlier this month that the FDA has cleared its investigational new drug application for PM359 for the treatment of

๐“๐ก๐ž ๐…๐ƒ๐€ ๐‡๐š๐ฌ ๐‚๐ฅ๐ž๐š๐ซ๐ž๐ ๐ญ๐ก๐ž ๐…๐ข๐ซ๐ฌ๐ญ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐š ๐๐ซ๐ข๐ฆ๐ž ๐„๐๐ข๐ญ๐จ๐ซ

Prime Medicine announced earlier this month that the FDA has cleared its investigational new drug application for PM359 for the treatment of
account_circle
CRISPR Medicine(@CrisprMedicine) 's Twitter Profile Photo

๐๐š๐ฌ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐‚๐จ๐ซ๐ซ๐ž๐œ๐ญ๐ฌ ๐‚๐จ๐ฆ๐ฆ๐จ๐ง ๐‡a๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐€ ๐Œ๐ฎ๐ญ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ ๐‘๐ž๐ฌ๐ญ๐จ๐ซ๐ž๐ฌ ๐…๐š๐œ๐ญ๐จ๐ซ ๐•๐ˆ๐ˆ๐ˆ ๐„๐ฑ๐ฉ๐ซ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐ข๐ง ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐Œ๐จ๐๐ž๐ฅ๐ฌ

Scientists at University of Ferrara and Universitร  degli Studi del Piemonte

๐๐š๐ฌ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐‚๐จ๐ซ๐ซ๐ž๐œ๐ญ๐ฌ ๐‚๐จ๐ฆ๐ฆ๐จ๐ง ๐‡a๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐€ ๐Œ๐ฎ๐ญ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ ๐‘๐ž๐ฌ๐ญ๐จ๐ซ๐ž๐ฌ ๐…๐š๐œ๐ญ๐จ๐ซ ๐•๐ˆ๐ˆ๐ˆ ๐„๐ฑ๐ฉ๐ซ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐ข๐ง ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐Œ๐จ๐๐ž๐ฅ๐ฌ

Scientists at University of Ferrara and Universitร  degli Studi del Piemonte
account_circle
CRISPR Medicine(@CrisprMedicine) 's Twitter Profile Photo

๐‚๐‘๐ˆ๐’๐๐‘๐Œ๐„๐ƒ24 ๐ข๐ฌ ๐š ๐ฐ๐ซ๐š๐ฉ, ๐š๐ง๐ ๐ก๐ž๐ซ๐ž'๐ฌ ๐ญ๐จ ๐‚๐‘๐ˆ๐’๐๐‘๐Œ๐„๐ƒ25!

A few words from CMN's editor Karen O'Hanlon Cohrt about the inaugural CRISPR Medicine Conference.

crisprmedicinenews.com/news/crisprmedโ€ฆ

news

๐‚๐‘๐ˆ๐’๐๐‘๐Œ๐„๐ƒ24 ๐ข๐ฌ ๐š ๐ฐ๐ซ๐š๐ฉ, ๐š๐ง๐ ๐ก๐ž๐ซ๐ž'๐ฌ ๐ญ๐จ ๐‚๐‘๐ˆ๐’๐๐‘๐Œ๐„๐ƒ25!

A few words from CMN's editor Karen O'Hanlon Cohrt about the inaugural CRISPR Medicine Conference.

crisprmedicinenews.com/news/crisprmedโ€ฆ

#crisprmedicinenews #crisprmedicine #crisprmed24 #crisprmed25
account_circle
Vivlion GmbH(@vivlion_gmbh) 's Twitter Profile Photo

Proud to support the firstย CRISPR Medicine Conference in Copenhagen (Denmark), April 23-25 2024.ย Complete your early bird registration until 12th January (event.fourwaves.com/crisprmed24/paโ€ฆ) & join scientific discussions about the medical impact of gene editing. CRISPR Medicine

Proud to support the firstย CRISPR Medicine Conference #CRISPRMED24 in Copenhagen (Denmark), April 23-25 2024.ย Complete your early bird registration until 12th January (event.fourwaves.com/crisprmed24/paโ€ฆ) & join scientific discussions about the medical impact of gene editing. @CrisprMedicine
account_circle
CRISPR Medicine(@CrisprMedicine) 's Twitter Profile Photo

๐€๐ง๐จ๐ญ๐ก๐ž๐ซ ๐ฐ๐ž๐ž๐ค, ๐š๐ง๐จ๐ญ๐ก๐ž๐ซ ๐ง๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ ๐Ÿ๐ซ๐จ๐ฆ ๐‚๐Œ๐, ๐ฒ๐จ๐ฎ๐ซ ๐จ๐ง๐ž-๐ฌ๐ญ๐จ๐ฉ ๐ฌ๐ก๐จ๐ฉ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ง๐ž๐ฐ๐ฌ ๐ข๐ง ๐‚๐‘๐ˆ๐’๐๐‘ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž.

Enjoy and have a great weekend all!

crisprmedicinenews.com/news/cmn-weeklโ€ฆ

๐€๐ง๐จ๐ญ๐ก๐ž๐ซ ๐ฐ๐ž๐ž๐ค, ๐š๐ง๐จ๐ญ๐ก๐ž๐ซ ๐ง๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ ๐Ÿ๐ซ๐จ๐ฆ ๐‚๐Œ๐, ๐ฒ๐จ๐ฎ๐ซ ๐จ๐ง๐ž-๐ฌ๐ญ๐จ๐ฉ ๐ฌ๐ก๐จ๐ฉ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ง๐ž๐ฐ๐ฌ ๐ข๐ง ๐‚๐‘๐ˆ๐’๐๐‘ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž.

Enjoy and have a great weekend all!

crisprmedicinenews.com/news/cmn-weeklโ€ฆ

#crisprmedicinenews
account_circle
Dan Fisher(@GeneEditingDan) 's Twitter Profile Photo

Itโ€™s been a fantastic 1st CRISPRMED24 conference! Rivaling the top CRISPR conferences! Special thanks to Jens-Ole Bock, quite a special person ๐Ÿ˜Š, and the entire CRISPR Medicine team to pull off the difficult task of assembling a conference. Looking forward to next year!

Itโ€™s been a fantastic 1st CRISPRMED24 conference!  Rivaling the top CRISPR conferences!  Special thanks to Jens-Ole Bock, quite a special person ๐Ÿ˜Š, and the entire @CrisprMedicine team to pull off the difficult task of assembling a conference.  Looking forward to next year!
account_circle
Cytosurge Inc.(@cytosurge) 's Twitter Profile Photo

Join us for the FIRST CRISPR Medicine conference, April 23-25 in Copenhagen! ๐Ÿงฌ Dr. Adele Kerjouan, Product Manager for CellEDIT, will be there to discuss the latest CRISPR advancements with global experts. Interested in exploring CellEDIT workflow via direct intra-nuclear

Join us for the FIRST @CrisprMedicine conference, April 23-25 in Copenhagen! ๐Ÿงฌ Dr. Adele Kerjouan, Product Manager for CellEDIT, will be there to discuss the latest CRISPR advancements with global experts. Interested in exploring CellEDIT workflow via direct intra-nuclear
account_circle
CRISPR Medicine(@CrisprMedicine) 's Twitter Profile Photo

๐“๐ก๐ž ๐…๐ƒ๐€ ๐‡๐š๐ฌ ๐‚๐ฅ๐ž๐š๐ซ๐ž๐ ๐ญ๐ก๐ž ๐…๐ข๐ซ๐ฌ๐ญ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐š ๐๐ซ๐ข๐ฆ๐ž ๐„๐๐ข๐ญ๐จ๐ซ

Prime Medicine announced this week that the FDA has cleared its investigational new drug application for PM359 for the treatment of chronic

๐“๐ก๐ž ๐…๐ƒ๐€ ๐‡๐š๐ฌ ๐‚๐ฅ๐ž๐š๐ซ๐ž๐ ๐ญ๐ก๐ž ๐…๐ข๐ซ๐ฌ๐ญ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐š ๐๐ซ๐ข๐ฆ๐ž ๐„๐๐ข๐ญ๐จ๐ซ

Prime Medicine announced this week that the FDA has cleared its investigational new drug application for PM359 for the treatment of chronic
account_circle